Literature DB >> 29757478

Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatum.

Ellie-Anna Minogianis1, Waqqas M Shams2, Omar S Mabrouk3, Jenny-Marie T Wong4, Wayne G Brake2, Robert T Kennedy3,4, Patrick du Souich1, Anne-Noël Samaha1,5.   

Abstract

The faster drugs of abuse reach the brain, the greater is the risk of addiction. Even small differences in the rate of drug delivery can influence outcome. Infusing cocaine intravenously over 5 vs. 90-100 s promotes sensitization to the psychomotor and incentive motivational effects of the drug and preferentially recruits mesocorticolimbic regions. It remains unclear whether these effects are due to differences in how fast and/or how much drug reaches the brain. Here, we predicted that varying the rate of intravenous cocaine infusion between 5 and 90 s produces different rates of rise of brain drug concentrations, while producing similar peak concentrations. Freely moving male Wistar rats received acute intravenous cocaine infusions (2.0 mg/kg/infusion) over 5, 45 and 90 s. We measured cocaine concentrations in the dorsal striatum using rapid-sampling microdialysis (1 sample/min) and high-performance liquid chromatography-tandem mass spectrometry. We also measured extracellular concentrations of dopamine and other neurochemicals. Regardless of infusion rate, acute cocaine did not change concentrations of non-dopaminergic neurochemicals. Infusion rate did not significantly influence peak concentrations of cocaine or dopamine, but concentrations increased faster following 5-s infusions. We also assessed psychomotor activity as a function of cocaine infusion rate. Infusion rate did not significantly influence total locomotion, but locomotion increased earlier following 5-s infusions. Thus, small differences in the rate of cocaine delivery influence both the rate of rise of drug and dopamine concentrations, and psychomotor activity. A faster rate of rise of drug and dopamine concentrations might be an important issue in making rapidly delivered cocaine more addictive.
© 2018 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  cocaine addiction; in vivo microdialysis; locomotor activity; male Wistar rats; pharmacokinetics

Mesh:

Substances:

Year:  2018        PMID: 29757478      PMCID: PMC6296906          DOI: 10.1111/ejn.13941

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  62 in total

1.  Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.

Authors:  G M Miller; S M Yatin; R De La Garza; M Goulet; B K Madras
Journal:  Brain Res Mol Brain Res       Date:  2001-02-19

2.  Comparison between intraperitoneal and oral methylphenidate administration: A microdialysis and locomotor activity study.

Authors:  M R Gerasimov; M Franceschi; N D Volkow; A Gifford; S J Gatley; D Marsteller; P E Molina; S L Dewey
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

3.  Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans.

Authors:  L A Marsch; W K Bickel; G J Badger; J P Rathmell; M D Swedberg; B Jonzon; C Norsten-Höög
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

4.  Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans.

Authors:  S D Comer; E D Collins; R B MacArthur; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  1999-04       Impact factor: 4.530

5.  Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans.

Authors:  M E Abreu; G E Bigelow; L Fleisher; S L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2001-02       Impact factor: 4.530

6.  Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.

Authors:  H S Chow; Z Chen; G T Matsuura
Journal:  J Pharm Sci       Date:  1999-08       Impact factor: 3.534

Review 7.  Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions.

Authors:  Y Zhang; T M Loonam; P A Noailles; J A Angulo
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

8.  Effects of route of administration on cocaine induced dopamine transporter blockade in the human brain.

Authors:  N D Volkow; G J Wang; M W Fischman; R Foltin; J S Fowler; D Franceschi; M Franceschi; J Logan; S J Gatley; C Wong; Y S Ding; R Hitzemann; N Pappas
Journal:  Life Sci       Date:  2000-08-11       Impact factor: 5.037

9.  Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats.

Authors:  E A Kiyatkin; D E Kiyatkin; G V Rebec
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

10.  Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

Authors:  R B Rothman; M H Baumann; C M Dersch; D V Romero; K C Rice; F I Carroll; J S Partilla
Journal:  Synapse       Date:  2001-01       Impact factor: 2.562

View more
  9 in total

1.  Intermittent intake of rapid cocaine injections promotes the risk of relapse and increases mesocorticolimbic BDNF levels during abstinence.

Authors:  Aliou B Gueye; Florence Allain; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2018-10-26       Impact factor: 7.853

2.  Re-examining the role of ventral tegmental area dopaminergic neurons in motor activity and reinforcement by chemogenetic and optogenetic manipulation in mice.

Authors:  Man-Yi Jing; Xiao Han; Tai-Yun Zhao; Zhi-Yuan Wang; Guan-Yi Lu; Ning Wu; Rui Song; Jin Li
Journal:  Metab Brain Dis       Date:  2019-07-16       Impact factor: 3.584

3.  Impact of delivery rate on the acute response to intravenous nicotine: A human laboratory study with implications for regulatory science.

Authors:  Joao P De Aquino; R Ross MacLean; Ralitza Gueorguieva; Elise E DeVito; Tore Eid; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2022-03       Impact factor: 4.280

4.  Hold-down as an alternative to unit dose in cocaine self-administration experiments: Characterization using a progressive ratio schedule.

Authors:  David C S Roberts; Benjamin A Zimmer
Journal:  Psychopharmacology (Berl)       Date:  2020-05-28       Impact factor: 4.530

5.  Addiction in focus: molecular mechanisms, model systems, circuit maps, risk prediction and the quest for effective interventions.

Authors:  Rita Z Goldstein; Michel Barrot; Barry J Everitt; John J Foxe
Journal:  Eur J Neurosci       Date:  2019-08       Impact factor: 3.386

6.  Amphetamine maintenance therapy during intermittent cocaine self-administration in rats attenuates psychomotor and dopamine sensitization and reduces addiction-like behavior.

Authors:  Florence Allain; Benoît Delignat-Lavaud; Marie-Pierre Beaudoin; Vincent Jacquemet; Terry E Robinson; Louis-Eric Trudeau; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2020-07-18       Impact factor: 7.853

7.  Cocaine-Induced Changes in Tonic Dopamine Concentrations Measured Using Multiple-Cyclic Square Wave Voltammetry in vivo.

Authors:  Jason Yuen; Abhinav Goyal; Aaron E Rusheen; Abbas Z Kouzani; Michael Berk; Jee Hyun Kim; Susannah J Tye; Charles D Blaha; Kevin E Bennet; Dong-Pyo Jang; Kendall H Lee; Hojin Shin; Yoonbae Oh
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 8.  The Critical Role of Peripheral Targets in Triggering Rapid Neural Effects of Intravenous Cocaine.

Authors:  Eugene A Kiyatkin
Journal:  Neuroscience       Date:  2020-10-01       Impact factor: 3.590

9.  Pharmacokinetics trumps pharmacodynamics during cocaine choice: a reconciliation with the dopamine hypothesis of addiction.

Authors:  Ludivine Canchy; Paul Girardeau; Audrey Durand; Caroline Vouillac-Mendoza; Serge H Ahmed
Journal:  Neuropsychopharmacology       Date:  2020-07-30       Impact factor: 7.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.